文献速递炎症性肠病

白细胞介素-22协调结肠上皮细胞病理性内质网应激转录程序

Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells.
PubMed 文献 · Gut · 2019-12-02

该研究探讨IL22在慢性结肠炎中的功能及对结肠上皮细胞的调控机制,利用三维迷你肠上皮类器官、体内疾病模型和人类IBD转录组数据。研究发现IL22不仅诱导抗菌反应转录模块,还协调内质网应激转录程序;活动性结肠克罗恩病患者结肠中IL22响应模块和内质网应激模块富集。靶向IL22可减轻结肠上皮内质网应激和结肠炎,IL12p40抗体阻断也减轻内质网应激反应,提示靶向IL22通路可能为结肠炎治疗策略。

要点

  • IL22在慢性结肠炎中协调结肠上皮细胞内质网应激转录程序。
  • 活动性结肠克罗恩病患者结肠中IL22响应和内质网应激模块富集。
  • 靶向IL22或调节内质网应激可减轻小鼠慢性结肠炎。

核心结论

  • IL22在慢性结肠炎中通过协调内质网应激转录程序发挥致病作用,挑战其纯有益细胞因子的观点。

研究设计与样本

  • 采用三维迷你肠上皮类器官系统、体内疾病模型和人类IBD转录组数据集研究IL22功能。
  • 研究注册号NCT02749630。

主要发现

  • IL22诱导结肠上皮细胞中抗菌反应转录模块和内质网应激反应转录程序。
  • 活动性结肠克罗恩病患者结肠中IL22响应转录模块和内质网应激反应模块富集。
  • 在IL22依赖性慢性结肠炎模型中,靶向IL22减轻结肠上皮内质网应激并缓解结肠炎。
  • 药物调节内质网应激反应同样影响结肠炎严重程度。
  • 结肠克罗恩病患者中IL12p40抗体阻断减轻结肠上皮内质网应激反应。

临床怎么用

  • 靶向IL22调节通路或缓解结肠上皮内质网应激可能成为结肠炎患者的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The functional role of interleukin-22 (IL22) in chronic inflammation is controversial, and mechanistic insights into how it regulates target tissue are lacking. In this study, we evaluated the functional role of IL22 in chronic colitis and probed mechanisms of IL22-mediated regulation of colonic epithelial cells. DESIGN: To investigate the functional role of IL22 in chronic colitis and how it regulates colonic epithelial cells, we employed a three-dimentional mini-gut epithelial organoid system, in vivo disease models and transcriptomic datasets in human IBD. RESULTS: As well as inducing transcriptional modules implicated in antimicrobial responses, IL22 also coordinated an endoplasmic reticulum (ER) stress response transcriptional programme in colonic epithelial cells. In the colon of patients with active colonic Crohn's disease (CD), there was enrichment of IL22-responsive transcriptional modules and ER stress response modules. Strikingly, in an IL22-dependent model of chronic colitis, targeting IL22 alleviated colonic epithelial ER stress and attenuated colitis. Pharmacological modulation of the ER stress response similarly impacted the severity of colitis. In patients with colonic CD, antibody blockade of IL12p40, which simultaneously blocks IL12 and IL23, the key upstream regulator of IL22 production, alleviated the colonic epithelial ER stress response. CONCLUSIONS: Our data challenge perceptions of IL22 as a predominantly beneficial cytokine in IBD and provide novel insights into the molecular mechanisms of IL22-mediated pathogenicity in chronic colitis. Targeting IL22-regulated pathways and alleviating colonic epithelial ER stress may represent promising therapeutic strategies in patients with colitis. TRIAL REGISTRATION NUMBER: NCT02749630.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Powell N, Pantazi E, Pavlidis P, et al. Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells. Gut. 2019. PMID: 31792136. doi:10.1136/gutjnl-2019-318483

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。